Identifying Key The...
OxiGene Inc. (OXGN: NASDAQ)
$1.23 -0.03 | -2.37%
02/09/12 - 01:24 PM ET
240.08K / 457.60K
Vol / Avg. Vol:1.27 / 1.26
Open / Prev. Close:1.23 - 1.29
Today's Range:0.82 - 6.38
52 Wk Range:27.27%
Performance YTD:TheStreet Rating:
Portfolios with OXGN
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorSmall-Cap Stocks in Danger ...
- UserMy Portfolio
- UserMy Portfolio
- Contributor5 Drug Stock Losers of 2010
- UserASCO 2010 Part 2
- UserBIN
- UserJBOND Portfolio 1
- UserASCO 2009 Nymph's Watch List.
- UserHot Biotech Stocks II
Latest OXGN Headlines from TheStreet
- 5 Breakout Stocks to Eye for a Buy 01.20.12 | 03:01 pm
- ASCO: Cancer Stock Winners, Losers 05.19.11 | 10:05 am
- ASCO: Traders Love Speculative Cancer Stocks 05.19.11 | 06:05 am
- Biotech Stock Mailbag: Celsion 05.13.11 | 08:05 am
- OXiGene: Small-Cap Winners 05.12.11 | 11:05 am
- TiVo: Small-Cap Winner 04.20.11 | 01:04 pm
- OXiGENE To Collaborate With NCI/CTEP, GOG On Phase 2 Study Of ZYBRESTAT In Patients With Relapsed Ovarian Cancer 02.14.11 | 08:02 am
- OXiGENE Provides Update On Near-Term Corporate Events 02.10.11 | 07:02 am
- OXiGENE To Present At BIO CEO And Investor Conference On February 14, 2011 02.04.11 | 08:02 am
- OXiGENE Enters Into Exchange Agreements With Warrant Holders 01.19.11 | 08:01 am
Press Releases for OXGN
Partner Headlines for OXGN
- OXiGENE Announces Changes to Board of Directors - Benzinga 09.09.11 | 04:09 pm
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- ZYBRESTAT Results Suggest Improvement in Overall Survival in Phase 2/3 Study in Anaplastic Thyroid Cancer - Benzinga 06.06.11 | 04:06 pm
- Morning Market Movers - Benzinga 06.06.11 | 09:06 am
- 7 Big Movers That Investors Must Watch This Week - Seeking Alpha 06.06.11 | 08:06 am
- ASCO 2011: Opportunities for Biotech Investor Success and Failure - Seeking Alpha 05.02.11 | 09:05 am
- UPDATE 1-Oxigene reports positive data on cancer drug - Reuters 10.11.10 | 08:10 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- UPDATE 1-Oxigene says auditors raise going concern doubts - Reuters 03.19.10 | 08:03 am
- UPDATE 1-Oxigene to cut half the jobs, sees Q1 charge - Reuters 02.11.10 | 11:02 am





